Brain pacemaker trial aims to cut seizures in kids with severe epilepsy
NCT ID NCT06924086
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether deep brain stimulation (DBS) can safely reduce seizures in children aged 5-14 with Lennox-Gastaut syndrome, a severe form of epilepsy. The trial uses a special device called Picostim to send electrical pulses to the brain. Researchers will track seizure frequency using caregiver diaries and EEG recordings. The goal is to improve seizure control, not to cure the condition.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LENNOX GASTAUT SYNDROME (LGS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Great Ormond Street Hospital NHS Foundation Trust
RECRUITINGLondon, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Smart brain pacemaker aims to stop seizures while you sleep
- EEG clues may reveal who benefits from seizure drug
- Wearable EEG gadget aims to perfect seizure drug dosing at home
- Study tests safer switch from street CBD to approved drug for kids with severe epilepsy
- Seizure drug safety trial halted early for dravet and LGS patients
- New drug shows promise for Tough-to-Treat seizures in kids